Natural Killer cells are a type of lymphocyte belonging to the innate immune system and they operate cell-mediated cytotoxicity and release of pro-inflammatory cytokines against cancerous cells. However, in vivo testings have shown a reduced activity of NK cells against solid tumors probably due to the negative influence of the immunosuppressive tumor microenvironment. Multicellular tumor spheroids may constitute an advantageous model in cancer biology for studying the mechanisms behind cancer immune editing since it more closely mimics the complexity of the human body compared with the 2D model counterpart. This study investigated the interaction between NK cells isolated from blood and tumor spheroids obtained from A498 renal carcinoma ce...
Metastasis of primary tumor accounts for 90% of all deaths in cancer patients. Interaction between c...
In vitro 3D cell culture systems utilizing multicellular tumor spheroids (MCTS) are widely used in t...
Abstract Background Immunotherapies still fail to benefit colorectal cancer (CRC) patients. Relevant...
Natural Killer cells are a type of lymphocyte belonging to the innate immune system and they operate...
In recent decades, cancer therapy research has shifted from broad-spectrum treatments to specialized...
Background: The complex cellular networks within tumors, the cytokine milieu, and tumor immune escap...
The purpose of this project was to study the migration patterns of human immune cells in response to...
NK cells are large granular lymphocytes that patrol the body for defect or virally infected cells. T...
Several approaches have shown that the immune response against tumors strongly affects patients’ cli...
Introduction<p>Ex vivo-expanded natural killer (NK) cells are a potential candidate for cancer immun...
Introduction<p>Ex vivo-expanded natural killer (NK) cells are a potential candidate for cancer immun...
The immune system provides defense against infectious agents such as viruses, bacteria and parasites...
Introduction<p>Ex vivo-expanded natural killer (NK) cells are a potential candidate for cancer immun...
SummaryRecognition of NKG2D ligands by natural killer (NK) cells plays an important role during anti...
The latest advancements in oncology research are focused on autologous immune cell therapy. However,...
Metastasis of primary tumor accounts for 90% of all deaths in cancer patients. Interaction between c...
In vitro 3D cell culture systems utilizing multicellular tumor spheroids (MCTS) are widely used in t...
Abstract Background Immunotherapies still fail to benefit colorectal cancer (CRC) patients. Relevant...
Natural Killer cells are a type of lymphocyte belonging to the innate immune system and they operate...
In recent decades, cancer therapy research has shifted from broad-spectrum treatments to specialized...
Background: The complex cellular networks within tumors, the cytokine milieu, and tumor immune escap...
The purpose of this project was to study the migration patterns of human immune cells in response to...
NK cells are large granular lymphocytes that patrol the body for defect or virally infected cells. T...
Several approaches have shown that the immune response against tumors strongly affects patients’ cli...
Introduction<p>Ex vivo-expanded natural killer (NK) cells are a potential candidate for cancer immun...
Introduction<p>Ex vivo-expanded natural killer (NK) cells are a potential candidate for cancer immun...
The immune system provides defense against infectious agents such as viruses, bacteria and parasites...
Introduction<p>Ex vivo-expanded natural killer (NK) cells are a potential candidate for cancer immun...
SummaryRecognition of NKG2D ligands by natural killer (NK) cells plays an important role during anti...
The latest advancements in oncology research are focused on autologous immune cell therapy. However,...
Metastasis of primary tumor accounts for 90% of all deaths in cancer patients. Interaction between c...
In vitro 3D cell culture systems utilizing multicellular tumor spheroids (MCTS) are widely used in t...
Abstract Background Immunotherapies still fail to benefit colorectal cancer (CRC) patients. Relevant...